Medicare deploys AI to flag fraud—but seniors must prove claims are legit

What it does

This bill creates a 2-year pilot program requiring Medicare to use artificial intelligence algorithms to score the risk of fraud in claims for durable medical equipment and lab tests. Beneficiaries who opt in will receive alerts when their claims are flagged as high-risk, and they can dispute the score before payment is suspended; Medicare staff will make final decisions on whether to block transactions.

Why we flagged it

The bill's core function is to establish a time-limited AI-driven fraud-detection system for specific Medicare claim types. It is not a broad policy change but a targeted pilot with voluntary beneficiary participation.

What the text implies

• Beneficiaries must opt into electronic notices to participate; seniors without digital access or comfort may be excluded from fraud protections, creating a two-tier system.
• The bill does not specify accuracy standards, appeal rights, or liability if the algorithm incorrectly flags legitimate claims, leaving beneficiaries vulnerable to payment delays without clear recourse.
• Medicare can terminate cards or issue new ones based on algorithm scores without explicit statutory limits, potentially disrupting access to care mid-treatment.
• The pilot focuses on durable medical equipment and lab tests—sectors with known supplier fraud—but does not address whether suppliers will face equivalent scrutiny or transparency about how their data is scored.

Who it affects

The bill may reduce fraud and protect beneficiary accounts, but it deploys AI scoring with limited transparency about how algorithms work, what data is used, or how accurate they are. Beneficiaries bear the burden of proving their claims are legitimate after being flagged, and the opt-in structure may exclude vulnerable seniors who don't use electronic notices.

Who stands to gain

• Medicare (reduced fraud losses)
• Durable medical equipment suppliers (those with legitimate billing patterns)
• Clinical diagnostic laboratories (those with legitimate billing patterns)

Named in the bill

Medicare, Department of Health and Human Services, Office of the Inspector General (HHS), Durable medical equipment suppliers, Clinical diagnostic laboratories, Executive Order 14179 (AI leadership)

Where it stands

• Jun 12, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jun 12, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.